WuXi AppTec

WuXi AppTec is a global contract research, development, and manufacturing organization (CRDMO) providing integrated services for the pharmaceutical and healthcare industries. Founded in 2000, the company supports drug discovery, development, and manufacturing across six primary segments: WuXi Chemistry, WuXi Testing, WuXi Biology, WuXi ATU, WuXi DDSU, and Others. Their technical platform facilitates the development of small molecules, oligonucleotides, peptides, and complex conjugates, enabling clients to accelerate drug development from target discovery to commercialization.

Operating with a workforce of 10,000+ employees, WuXi AppTec maintains a robust international footprint with four primary locations. The company leverages high-throughput screening, advanced R&D capabilities, and regulatory compliance testing to support global biopharmaceutical projects. Learn about WuXi AppTec's global headquarters for detailed geographic and operational insights. Their infrastructure is designed to provide flexible, full-time equivalent services that ensure rapid turnaround times and high-quality standards for complex synthetic molecular modalities.

The company demonstrates significant market scale, reporting annual revenue of $7.1B. Meet WuXi AppTec's team to understand the leadership driving their integrated testing and manufacturing solutions. As a key player in the global life science industry, WuXi AppTec continues to expand its technological reach through strategic investments and diverse service offerings. Explore financial highlights to review detailed metrics and funding history, including recent debt and stock issuance activities that support their ongoing expansion in the global pharmaceutical market.